Article
An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction.
Journal of thrombosis and thrombolysis - 1 Oct 2010
Carlquist John F, Horne Benjamin D, Mower Chrissa, Park James, Huntinghouse John, McKinney Jason T, Muhlestein Joseph B, Anderson Jeffrey L
Abstract excerpt
Warfarin anticoagulation is complicated by the highly variable inter-individual response. Approximately 50% of the dose variability arises from clinical factors and variants in two genes, CYP2C9 (*2 and *3 variants) and VKORC1 -1173 C > T. We tested variants in five additional genes (EPHX1, PROC,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
